drugset / Trial / NCT05857878
A Study to Test How Well Different Doses of BI 1815368 Are Tolerated by Healthy Men
RandomizedParallel-groupSingle-blindTreatment
Summary
This trial aims to investigate safety, tolerability, and pharmacokinetics following multiple rising doses of BI 1815368 in healthy male subjects.
Timeline
- Start
- 2023-06-23
- Primary completion
- 2024-06-06
- Completion
- 2024-06-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1815368 | Unknown | — | — |
Indications
No indication recorded.